UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular Cytotoxicity In Vivo

Journal of Virology, 2011-04, Vol.85 (7), p.3239-3249

2011

Volltextzugriff (PDF)

Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models

The Journal of clinical investigation, 2021-12, Vol.131 (23)

2021

Volltextzugriff (PDF)

Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone

Journal of Virology, 2011-10, Vol.85 (20), p.10472-10486

2011

Volltextzugriff (PDF)

Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs

Journal of Virology, 2014-02, Vol.88 (4), p.2000-2010

2014

Volltextzugriff (PDF)

Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread

Journal of Virology, 2012-04, Vol.86 (8), p.4586-4598

2012

Volltextzugriff (PDF)

Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine

Vaccine, 2009-11, Vol.27 (49), p.6845-6853

2009

Volltextzugriff (PDF)

A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine

Journal of Virology, 2008-09, Vol.82 (17), p.8431-8441

2008

Volltextzugriff (PDF)

Herpes Simplex Virus Type 1 and 2 Glycoprotein C Prevents Complement-Mediated Neutralization Induced by Natural Immunoglobulin M Antibody

Journal of Virology, 2006-04, Vol.80 (8), p.4038-4046

2006

Volltextzugriff (PDF)

Herpes Simplex Virus Type 1 Evades the Effects of Antibody and Complement In Vivo

Journal of Virology, 2002-09, Vol.76 (18), p.9232-9241

2002

Volltextzugriff (PDF)

Herpes simplex virus type 1 infection increases the carbohydrate binding activity and the secretion of cellular galectin-3

Archives of virology, 2009-04, Vol.154 (4), p.609-618

2009

Volltextzugriff (PDF)

An HSV-1 gD mutant virus as an entry-impaired live virus vaccine

Vaccine, 2008-02, Vol.26 (9), p.1195-1203

2008

Volltextzugriff (PDF)

Short Interfering RNA-Mediated Inhibition of Herpes Simplex Virus Type 1 Gene Expression and Function during Infection of Human Keratinocytes

Journal of Virology, 2004-10, Vol.78 (19), p.10276-10281

2004

Volltextzugriff (PDF)

Immunization Strategies To Block the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor

Journal of Virology, 2004-03, Vol.78 (5), p.2562-2571

2004

Volltextzugriff (PDF)

Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection

Journal of Virology, 2003-12, Vol.77 (23), p.12639-12645

2003

Volltextzugriff (PDF)

Novel Mechanism of Antibody-Independent Complement Neutralization of Herpes Simplex Virus Type 1

The Journal of immunology (1950), 2000-10, Vol.165 (8), p.4528-4536

2000

Volltextzugriff (PDF)

In Vivo Immune Evasion Mediated by the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor

Journal of Virology, 1998-07, Vol.72 (7), p.5351-5359

1998

Volltextzugriff (PDF)

Preventing neonatal herpes: Protection after maternal mRNA-lipid nanoparticle vaccination equals or exceeds that from prior maternal genital infection in murine models

The Journal of immunology (1950), 2022-05, Vol.208 (1_Supplement), p.64-64.10

2022

Volltextzugriff (PDF)

Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains

Vaccine, 2005-09, Vol.23 (38), p.4658-4665

2005

Volltextzugriff (PDF)

Herpes Simplex Virus Type 1 Glycoprotein gC Mediates Immune Evasion In Vivo

Journal of Virology, 1998-10, Vol.72 (10), p.8257-8263

1998

Volltextzugriff (PDF)

Herpes Simplex Virus Type 1 Glycoprotein E Domains Involved in Virus Spread and Disease

Journal of Virology, 2000-08, Vol.74 (15), p.6712-6719

2000

Volltextzugriff (PDF)

The gH-gL Complex of Herpes Simplex Virus (HSV) Stimulates Neutralizing Antibody and Protects Mice against HSV Type 1 Challenge

Journal of Virology, 1998-01, Vol.72 (1), p.65-72

1998

Volltextzugriff (PDF)

Le processus de renouvellement des licences d’exploitation des réacteurs nucléaires aux Etats-Unis

Revue général nucléaire, 2014-05 (3), p.22-23

2014

Volltextzugriff (PDF)

In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC

The Journal of experimental medicine, 1999-12, Vol.190 (11), p.1637-1646

1999

Volltextzugriff (PDF)

Exogenous siRNA Mediates Sequence-Independent Gene Suppression by Signaling through Toll-Like Receptor 3

Cells, tissues, organs, 2004-01, Vol.177 (3), p.132-138

2004

Volltextzugriff (PDF)

1 – 25 von 238

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(225)
Mit Volltextzugriff
(209)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Herpes Simplex Virus 1 IgG Fc Receptor Blocks Antibody-Mediated Complement Activation and Antibody-Dependent Cellular Cytotoxicity In Vivo

Trivalent nucleoside-modified mRNA vaccine yields durable memory B cell protection against genital herpes in preclinical models

Immunization with a Vaccine Combining Herpes Simplex Virus 2 (HSV-2) Glycoprotein C (gC) and gD Subunits Improves the Protection of Dorsal Root Ganglia in Mice and Reduces the Frequency of Recurrent Vaginal Shedding of HSV-2 DNA in Guinea Pigs Compared to Immunization with gD Alone

Novel Adjuvant S-540956 Targets Lymph Nodes and Reduces Genital Recurrences and Vaginal Shedding of HSV-2 DNA When Administered with HSV-2 Glycoprotein D as a Therapeutic Vaccine in Guinea Pigs

Protection Provided by a Herpes Simplex Virus 2 (HSV-2) Glycoprotein C and D Subunit Antigen Vaccine against Genital HSV-2 Infection in HSV-1-Seropositive Guinea Pigs

Live Attenuated Herpes Simplex Virus 2 Glycoprotein E Deletion Mutant as a Vaccine Candidate Defective in Neuronal Spread

Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine

A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine

Herpes Simplex Virus Type 1 and 2 Glycoprotein C Prevents Complement-Mediated Neutralization Induced by Natural Immunoglobulin M Antibody

Herpes Simplex Virus Type 1 Evades the Effects of Antibody and Complement In Vivo

Herpes simplex virus type 1 infection increases the carbohydrate binding activity and the secretion of cellular galectin-3

An HSV-1 gD mutant virus as an entry-impaired live virus vaccine

Short Interfering RNA-Mediated Inhibition of Herpes Simplex Virus Type 1 Gene Expression and Function during Infection of Human Keratinocytes

Immunization Strategies To Block the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor

Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection

Novel Mechanism of Antibody-Independent Complement Neutralization of Herpes Simplex Virus Type 1

In Vivo Immune Evasion Mediated by the Herpes Simplex Virus Type 1 Immunoglobulin G Fc Receptor

Preventing neonatal herpes: Protection after maternal mRNA-lipid nanoparticle vaccination equals or exceeds that from prior maternal genital infection in murine models

Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains

Herpes Simplex Virus Type 1 Glycoprotein gC Mediates Immune Evasion In Vivo

Herpes Simplex Virus Type 1 Glycoprotein E Domains Involved in Virus Spread and Disease

The gH-gL Complex of Herpes Simplex Virus (HSV) Stimulates Neutralizing Antibody and Protects Mice against HSV Type 1 Challenge

Le processus de renouvellement des licences d’exploitation des réacteurs nucléaires aux Etats-Unis

In vivo role of complement-interacting domains of herpes simplex virus type 1 glycoprotein gC

Exogenous siRNA Mediates Sequence-Independent Gene Suppression by Signaling through Toll-Like Receptor 3

Suchergebnisse filtern